TACTICS: TACE Plus Sorafenib Improves PFS in Unresectable HCC ...Middle East

Combining transcatheter arterial chemoembolization (TACE) therapy with sorafenib improved progression-free survival (PFS), but not overall survival (OS), when compared with TACE alone. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( TACTICS: TACE Plus Sorafenib Improves PFS in Unresectable HCC )

Also on site :

• I Use This Solar-Powered Security Camera to Keep My Home Safe, and It's $24 Off for Prime Day
• Merck spends $10 billion for Verona, gaining access to its COPD medication
• Perris mayor tells residents to stay inside after reports of ICE activity